Journal of Headache and Pain

Papers
(The TQCC of Journal of Headache and Pain is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis142
CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine116
Using natural language processing to automatically classify written self-reported narratives by patients with migraine or cluster headache88
Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency82
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients67
Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study64
Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia51
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine49
Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China48
Measuring interictal burden among people affected by migraine: a descriptive survey study46
Debate: Are cluster headache and migraine distinct headache disorders?40
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results37
Total tenderness score and pressure pain thresholds in persistent post-traumatic headache attributed to mild traumatic brain injury36
Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting35
HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain35
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study35
Tracking the evolution of non-headache symptoms through the migraine attack31
Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling study31
Development and validation of a novel model for characterizing migraine outcomes within real-world data31
0.12507009506226